China DRG Industry Roundtable

China’s DRG reform has been piloted in more than 30 cities to curb the exponential healthcare expenditure growth and to find a more cost-effective solution for health service delivery. The sweeping DRG pilots carried out in hospitals at all levels could significantly affect the pricing and procurement of MedTech products and devices.

This session serves to enable lively discussions between industry stakeholders, trade association and policymakers about changes to be faced by the MedTech industry under the theme of DRG reforms in China. The dialogue will include learnings from APAC on DRG-based procurement.

This is a closed-door event. For more information, please contact [email protected].